Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections, including respiratory, sinus, skin and soft‑tissue infections, and is used in combination regimens for Helicobacter pylori eradication. GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Klacid is a macrolide antibiotic used to treat bacterial infections in several organ systems. - Community‑acquired pneumonia: clears bacterial infection of the lungs and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and bacterial load, relieving congestion and pain. - Acute exacerbations of chronic bronchitis: controls bacterial flare‑ups and helps restore normal breathing. - Skin and soft‑tissue infections: eradicates susceptible bacteria causing cellulitis, impetigo and wound infections. - Helicobacter pylori eradication (in combination therapy): contributes to bacterial clearance as part of triple‑therapy regimens. - Atypical mycobacterial infections: provides activity against certain non‑tuberculous mycobacteria.

Clarithromycin may cause a range of adverse reactions, from mild to severe. Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered or metallic taste. - Vomiting: occasional emesis. - Headache: mild to moderate headache. Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, anaphylaxis. - Clostridioides difficile‑associated diarrhea: severe colitis. - Liver enzyme elevation: hepatitis or jaundice. - QT interval prolongation: risk of cardiac arrhythmias. - Arrhythmias: ventricular tachycardia or torsades de pointes. - Anaphylaxis: life‑threatening hypersensitivity.

Before prescribing Klacid, clinicians should consider several safety measures. - Renal function assessment: adjust use in patients with impaired kidney function. - Liver monitoring: check hepatic enzymes during prolonged therapy. - QT prolongation risk: avoid in patients with known cardiac conduction disorders. - Hypersensitivity check: do not use in individuals with known macrolide allergy. - Concomitant medication review: evaluate for potential drug‑drug interactions. - Store at ambient temperature: keep in the original container, protect from moisture.

Clarithromycin interacts with several medicines; awareness of the interaction level guides clinical decisions. Major Interactions (Avoid): - Cisapride and pimozide: risk of serious cardiac arrhythmias. - Simvastatin and other CYP3A4 substrates: increased statin levels leading to myopathy. - Ergot alkaloids: potential ergotism due to elevated plasma concentrations. - Colchicine: heightened toxicity, especially in renal impairment. Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce clarithromycin absorption. - Digoxin: possible increase in serum digoxin levels. - Oral contraceptives: may reduce contraceptive efficacy, requiring additional methods.